Ionis Pharmaceuticals, Inc. is an American biotechnology company specializing in the development of RNA-targeted therapies for the treatment of various severe diseases. The company utilizes advanced antisense oligonucleotide (ASO) technology, which allows for targeted modification of RNA and regulation of gene expression, useful in treating conditions such as amyotrophic lateral sclerosis (ALS), Duchenne muscular dystrophy, and various genetic disorders. Ionis Pharmaceuticals is a leader in innovative treatment approaches, offering new possibilities for patients with previously untreatable diseases.
Feed
There are no posts to show right now.
Używamy ciasteczek, aby ulepszyć Twoje doświadczenie na naszej stronie.
